Fig. 2: Per capita economic burden of diabetes mellitus in 2020–2050 (in 2017 INT$).
The map displays the projected per capita economic burden of diabetes mellitus in 204 countries and territories from 2020 to 2050, expressed in 2017 international dollars adjusted for purchasing power. Darker shades indicate higher per capita losses. The highest burdens (≥INT$2,994 per person) are observed in countries including American Samoa, Australia and Brunei Darussalam, highlighting the substantial impact on individuals in high-income and island economies. Intermediate burden levels (INT$595–INT$2,110 per person) are observed across parts of Europe, the Middle East and Southeast Asia, while many low-income countries, particularly in Africa, fall below INT$96 per person. Regional labels provide geographic orientation, and NA indicates countries or territories with missing data. By showing the burden on a per-person basis, this figure underscores stark inequalities in the economic consequences of diabetes across populations.
